These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23504607)

  • 21. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
    Kawakami K; Takahashi A; Yoshimoto T
    No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus.
    Litvinov RI; Nabiullina RM; Zubairova LD; Shakurova MA; Andrianova IA; Weisel JW
    Front Immunol; 2019; 10():1626. PubMed ID: 31379831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiological consequences of loss of plasminogen activator gene function in mice.
    Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
    Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinolysis and the risk of venous and arterial thrombosis.
    Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
    Curr Opin Hematol; 2007 May; 14(3):242-8. PubMed ID: 17414214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
    Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
    Francis RB; McGehee WG; Feinstein DI
    Thromb Haemost; 1988 Jun; 59(3):412-4. PubMed ID: 3142079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus.
    Somers EC; Marder W; Kaplan MJ; Brook RD; McCune WJ
    Ann N Y Acad Sci; 2005 Jun; 1051():271-80. PubMed ID: 16126968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasminogen activator of tissue type. Physiology, pathophysiology and clinical value].
    Korninger C
    Wien Klin Wochenschr; 1985 Nov; 97(22):832-40. PubMed ID: 2934899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosis.
    Lucking AJ; Gibson KR; Paterson EE; Faratian D; Ludlam CA; Boon NA; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):1105-11. PubMed ID: 23471234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.
    Larsson P; Alwis I; Niego B; Sashindranath M; Fogelstrand P; Wu MC; Glise L; Magnusson M; Daglas M; Bergh N; Jackson SP; Medcalf RL; Jern S
    J Thromb Haemost; 2016 Dec; 14(12):2496-2508. PubMed ID: 27706906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system.
    Sasajima T; Takano Y; Hiraishi Y; Goh K; Inaba M; Azuma N; Sasajima Y; Yamazaki K; Yamamoto H
    J Vasc Surg; 2000 Aug; 32(2):374-82. PubMed ID: 10917998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in systemic fibrinolysis and blood coagulation parameters in local thrombolysis with tissue plasminogen activator (rt-PA)].
    Klein P; Roth FJ; Rieger H; Popov-Cenic S
    Vasa; 1992; 21(3):249-52. PubMed ID: 1529628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA.
    Engesser L; Koopman J; de Munk G; Haverkate F; Nováková I; Verheijen JH; Briët E; Brommer EJ
    Thromb Haemost; 1988 Aug; 60(1):113-20. PubMed ID: 3142089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolysis in systemic lupus erythematosus: effect of desamino D-arginine vasopressin infusion.
    Belch JJ; Zoma A; McLaughlin K; Curran L; Capell HA; Forbes CD; Sturrock RD
    Br J Rheumatol; 1987 Aug; 26(4):262-6. PubMed ID: 3111577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrin-specific thrombolytic agents.
    Collen D
    Klin Wochenschr; 1988; 66 Suppl 12():15-23. PubMed ID: 3126344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator.
    Dzik WH; Arkin CF; Jenkins RL; Stump DC
    Blood; 1988 Apr; 71(4):1090-5. PubMed ID: 3128347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.